drugset / Trial / NCT00800956
Phase I Study to Determine the Absorption, Distribution, Metabolism and Excretion of Esreboxetine
Non-randomizedSingle-groupOpen-labelBasic science
Summary
The purpose of the study is to learn more about how esreboxetine is handled by the body i.e. the absorption, metabolism and excretion of esreboxetine.
Timeline
- Start
- 2009-01
- Primary completion
- 2009-02
- Completion
- 2009-02
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | [S,S]-Reboxetine | Unknown | 6 mg | Oral |
Indications
No indication recorded.